Ahmedabad (Gujarat) [India], July 14: Intas Pharmaceuticals Ltd. announced that the European Medicine Agency (EMA) confirms acceptance of the Marketing Authorization Application (MAA) for DMB-3115, a biosimilar of Stelara® (Ustekinumab). The MAA has been submitted by Accord Healthcare,
Washington [US], May 7 (ANI/Sputnik): The European Medicine Agency (EMA) said on Friday that its committee on vaccine safety asked AstraZeneca to provide additional trial data on its COVID-19 drug for an inquiry into cases of a rare autoimmune disorder following vaccination.